Tredje AP fonden Invests $6.12 Million in HCA Healthcare, Inc. $HCA

Tredje AP fonden purchased a new stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 13,112 shares of the company’s stock, valued at approximately $6,121,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Larson Financial Group LLC raised its stake in shares of HCA Healthcare by 13.5% during the fourth quarter. Larson Financial Group LLC now owns 805 shares of the company’s stock worth $376,000 after purchasing an additional 96 shares during the last quarter. Handelsbanken Fonder AB lifted its position in HCA Healthcare by 7.9% in the fourth quarter. Handelsbanken Fonder AB now owns 213,272 shares of the company’s stock valued at $99,568,000 after purchasing an additional 15,675 shares during the period. Hartford Funds Management Co LLC raised its stake in shares of HCA Healthcare by 56.0% during the 4th quarter. Hartford Funds Management Co LLC now owns 4,440 shares of the company’s stock worth $2,075,000 after buying an additional 1,593 shares in the last quarter. Profund Advisors LLC boosted its position in shares of HCA Healthcare by 25.4% during the 4th quarter. Profund Advisors LLC now owns 2,783 shares of the company’s stock worth $1,299,000 after purchasing an additional 564 shares in the last quarter. Finally, ProShare Advisors LLC boosted its holdings in HCA Healthcare by 6.1% during the fourth quarter. ProShare Advisors LLC now owns 30,403 shares of the company’s stock worth $14,194,000 after buying an additional 1,755 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HCA. Barclays reduced their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday, April 27th. JPMorgan Chase & Co. dropped their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday. Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Oppenheimer reduced their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.

View Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Stock Down 4.4%

Shares of NYSE HCA opened at $403.98 on Wednesday. The firm has a market cap of $89.62 billion, a PE ratio of 13.89, a price-to-earnings-growth ratio of 1.34 and a beta of 1.18. The business has a 50 day moving average price of $473.90 and a two-hundred day moving average price of $485.20. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.